Challenge continues in developing effective drug treatment for Alzheimer's disease
Nilvadipine shows no benefit for the treatment of Alzheimer's disease in mild and moderate stages of the disease, but further studies targeting the early phase of the disease may be warranted.
from Latest Science News -- ScienceDaily https://ift.tt/2zrNouF
from Latest Science News -- ScienceDaily https://ift.tt/2zrNouF
Comments
Post a Comment